Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy
- PMID: 9069478
- PMCID: PMC1064152
- DOI: 10.1136/jnnp.62.3.239
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy
Abstract
Objectives: Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's disease and five patients with progressive supranuclear palsy. The aim of the study was to assess the concentration of N-acetyl-aspartate (NAA), creatine and phosphocreatine (Cr), and choline containing compounds (Cho) in the putamen and globus pallidus of these patients.
Methods: Peak ratios obtained from patients were compared with those from nine healthy age matched controls.
Results: NAA/Cho and NAA/Cr ratios were reduced significantly in patients with progressive supranuclear palsy.
Conclusion: These results suggest an NAA deficit, due to neuronal loss, in the lentiform nucleus of these patients. 1H-MRS is a non-invasive technique that can provide useful information concerning striatal neuronal loss in the basal ganglia of patients with parkinsonian syndromes.
Similar articles
-
Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.Mov Disord. 1997 Nov;12(6):903-9. doi: 10.1002/mds.870120611. Mov Disord. 1997. PMID: 9399213
-
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.Brain. 1997 Sep;120 ( Pt 9):1541-52. doi: 10.1093/brain/120.9.1541. Brain. 1997. PMID: 9313638
-
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.Ital J Neurol Sci. 1999 Aug;20(4):223-9. doi: 10.1007/s100720050035. Ital J Neurol Sci. 1999. PMID: 10551908
-
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.Dement Geriatr Cogn Disord. 2002;14(2):64-76. doi: 10.1159/000064927. Dement Geriatr Cogn Disord. 2002. PMID: 12145453 Review.
-
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].Nihon Rinsho. 1997 Jan;55(1):249-54. Nihon Rinsho. 1997. PMID: 9014459 Review. Japanese.
Cited by
-
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017. Transl Neurodegener. 2017. PMID: 28360997 Free PMC article. Review.
-
Magnetic resonance imaging in progressive supranuclear palsy.J Neurol. 2011 Apr;258(4):549-58. doi: 10.1007/s00415-010-5865-0. Epub 2010 Dec 22. J Neurol. 2011. PMID: 21181185
-
Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.Korean J Radiol. 2002 Jul-Sep;3(3):180-8. doi: 10.3348/kjr.2002.3.3.180. Korean J Radiol. 2002. Retraction in: Korean J Radiol. 2007 Mar-Apr;8(2):184. doi: 10.3348/kjr.2007.8.2.184. PMID: 12271163 Free PMC article. Retracted.
-
Advanced Magnetic Resonance Imaging for Early Diagnosis and Monitoring of Movement Disorders.Brain Sci. 2025 Jan 16;15(1):79. doi: 10.3390/brainsci15010079. Brain Sci. 2025. PMID: 39851446 Free PMC article. Review.
-
Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.AJNR Am J Neuroradiol. 2001 Jan;22(1):143-51. AJNR Am J Neuroradiol. 2001. PMID: 11158900 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical